Download PDF
Pharmacopsychiatry 2003; 36: 176-180
DOI: 10.1055/s-2003-45127
Original Paper
© Georg Thieme Verlag Stuttgart · New York

Anhedonia, Self-Experience in Schizophrenia, and Implications for Treatment

G. Juckel1 , L. Sass2 , A. Heinz1
  • 1Department of Psychiatry and Psychotherapy, Charité - University Medicine Berlin, Campus Charité-Mitte (CCM), Berlin, Germany
  • 2Department of Clinical Psychology, GSAPP, Rutgers University, New Jersey, USA
Further Information

Publication History

Publication Date:
15 December 2003 (online)

Also available at
    Permissions and Reprints

Anhedonia - the inability to experience pleasure - is a symptom of several psychiatric disorders such as depression, drug and alcohol dependence, but also schizophrenia. The concept of anhedonia played a major role in psychiatric and psychoanalytic explanations of psychotic behavior. The relationship between notions of anhedonia and of mental evolution and regression (in the work of Myerson and Bleuler) is discussed. The non-evolutionist views of Rado and Meehl are described. Then the concept of anhedonia is discussed in relationship to the phenomenological approach of Sass and Parnas, who view anhedonia as one manifestation of a self-disturbance or self-disorder that is fundamental in schizophrenia. Concerning treatment of anhedonia, it was often hypothesized that anhedonia is associated with a dysfunction of the mesolimbic dopaminergic reward system. However, studies in humans and non-human animal models indicate that dysfunction of central dopaminergic neurotransmission interferes with the process of motivation rather than with the ability to experience pleasure; the latter may be more mediated by the opioidergic and serotonergic neurotransmission. Understanding the neurobiological correlates of motivation and pleasure may provide new options to treat anhedonia in patients with schizophrenia.

Key words

Anhedonia - self-disorder - motivation - neuroleptic treatment - schizophrenia

References

  • 1 Andreasen N C. Negative symptoms in schizophenia. Definition and reliability.  Arch Gen Psychiat. 1982;  39 784-788
    PubMedGoogle Scholar
  • 2 Artaud A. Antonin Artaud Anthology. edited by Jack Hirschman San Francisco CA; City Lights Books 1965
    Google Scholar
  • 3 Artaud A. Antonin Artaud: Selected Writings. edited by Susan Sontag, translated by Helen Weaver New York; Farrar, Straus, & Giroux 1976
    Google Scholar
  • 4 Bermazohn P C, Siris S G. Akinesia: a syndrom common to Parkinsonism, retarded depression, and negative symptoms of schizophrenia.  Comp Psychiat. 1992;  33 221-232
    PubMedGoogle Scholar
  • 5 Bernet R, Kern I, Marbach E. An Introduction to Husserlian Phenomenology. Evanston, IL; Northwestern University Press 1993
    Google Scholar
  • 6 Berridge K C, Robinson T E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?.  Brain Res Rev. 1998;  28 309-369
    CrossrefPubMedGoogle Scholar
  • 7 Berze J. Die Primäre Insuffizienz der Psychischen Aktivität: Ihr Wesen, ihre Erscheinungen und ihre Bedeutung als Grundstörungen der Dementia Praexox und den hypophrenen Überhaupt. Leipzig: F. Deuticke; 1914 (Excerpt translated: Berze J. Primary insufficiency of mental activity. In Cutting J, Shepherd M, editors The Clinical Roots of the Schizophrenia Concept. Cambridge, UK; Cambridge University Press 1987: pp. 51-58)
    Google Scholar
  • 8 Blankenburg W. First steps toward a psychopathology of ”common sense” (transl. A. Mishara). Philosophy, Psychiatry, Psychology 2001; 8 : 303 - 315 (Originally appeared as: Ansatze zu einer Psychopathologie des ‘common sense.  Confinia Psychiatrica. 1969;  12 144-163)
    PubMedGoogle Scholar
  • 9 Blankenburg W. Der Verlust der Naturlichen Selbstverstandlichkeit: Ein Beitrag zur Psychopathologie Symptomarmer Schizophrenien. Stuttgart; Ferdinand Enke Verlag 1971 (French translation: Blankenburg W. La Perte de L’Evidence Naturelle: Une Contribution a la Psychopathologie des Schizophrenies Pauci-Symptomatiques. Paris: Presses Universitaires de France; 1991). 
    Google Scholar
  • 10 Bleuler E. Dementia praecox oder die Gruppe der Schizophrenien. Berlin; Springer 1911
    Google Scholar
  • 11 Bleuler E. Das autistisch-undisziplinierte Denken in der Medizin und seine Ueberwindung. Berlin; Springer 1927
    Google Scholar
  • 12 Czihak G. Biologie. Berlin; Springer 1981
    Google Scholar
  • 13 Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.  Proc Natl Acad Sci. 1988;  85 5274-5278
    PubMedGoogle Scholar
  • 14 Dreyfus H. Intelligence without representation-Merleau-Ponty’s critique of mental representation.  Phenomenol Cogn Sci. 2002;  1 367-383
    PubMedGoogle Scholar
  • 15 Evans-Pritchard E E. Witchcarft, oracles, and maigc among the Azande. Oxford; Oxford University Press 1976
    Google Scholar
  • 16 Freud S. Totem und Tabu. In: Gesammelte Werke, Band IX. 5. Ausgabe Frankfurt; Fischer 1977
    Google Scholar
  • 17 Gard D E, Kring A M, Germans M K, Werner K. Emotion in the daily life of schizophrenia patients. Poster presented at Annual Meeting. Society for Research in Psychopathology Boulder, Colorado; 2000
    Google Scholar
  • 18 Gibson J J. The Ecological Approach to Visual Perception. Boston; Houghton Mifflin 1979
    Google Scholar
  • 19 Gould S J. Ontogeny and phylogeny. Cambridge; Harvard University Press 1977
    Google Scholar
  • 20 Harrow M, Yonan C A, Sands J R, Marengo J. Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved?.  Schizophren Bull. 1994;  20 327-338
    PubMedGoogle Scholar
  • 21 Heinrich K. Psychopathologie der Regression. Stuttgart; Schattauer 1984
    Google Scholar
  • 22 Heinz A. Savage thought and thoughtful savages - on the context of the evaluation of logical thought by Lévy-Bruhl and Evans-Pritchard.  Anthropos. 1997;  92 165-173
    PubMedGoogle Scholar
  • 23 Heinz A, Heinze M. From pleasure to anhedonia - frobidden desires and the construction of schizophrenia.  Theory Psychol. 1999;  9 47-65
    PubMedGoogle Scholar
  • 24 Heinz A, Schmidt L G, Reischies F M. Anhedonia in schizophrenic, depressed, or alcohol-dependent patients - neurobiological correlates.  Pharmacopsychiat. 1994;  27 (Suppl.) 7-10
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Heinz A, Leferink K, Bühmann Y, Heinze M. Autismus und Konkretismus - widersprüchliche Konzepte schizophrener Denkstörung?.  Fund Psychiat. 1995;  2 54-61
    PubMedGoogle Scholar
  • 26 Henry M. The Essence of Manifestation,. trans. G. Etzkorn The Hague; Martinus Nijhoff 1973 (Original in: L’Essence de la Manifestation. Paris: P.U.F. ; 1963). 
    Google Scholar
  • 27 Hume D. A treatise of human nature. Oxford; University Press 1978
    Google Scholar
  • 28 Jackson J H. Die Croon-Vorlesungen ueber Aufbau und Abbau des Nervensystems. Berlin; Springer 1927
    Google Scholar
  • 29 Kelley A E, Bakshi V P, Haber S N, Steininger T L, Will M J, Zhang M. Opioid modulation of taste hedonics within the vetral striatum.  Physiol Behav. 2002;  76 365-77
    CrossrefPubMedGoogle Scholar
  • 30 Klein D F. Endogenomorphic depression: a conceptual and terminological revision.  Arch Gen Psychiat. 1974;  31 447-554
    PubMedGoogle Scholar
  • 31 Koob G F, Le Moal M. Drug abuse: hedonic momeostatic dysregulation.  Science. 1997;  278 52-58
    Google Scholar
  • 32 Kring A. M. Emotion in schizophrenia: Old mystery, new understanding.  Curr Dir Psychol Sci. 1999;  8 160-163
    CrossrefPubMedGoogle Scholar
  • 33 Lévi-Strauss C. La pensée sauvage. Paris; Libraire Plon 1962
    Google Scholar
  • 34 Lévy-Bruhl L. How natives think. Princeton; Princeton University Press 1985
    Google Scholar
  • 35 Lyotard J F. The postmodern condition: a report on knowledge. Minneapolis; University of Minneapolis Press 1993
    Google Scholar
  • 36 Malinowski B. The sexual life of savages in North-Western Melanesia. Boston; Beacon Press 1987
    Google Scholar
  • 37 Meehl P E. Schizotaxia, schizotypy, schizophrenia.  Am Psychol. 1962;  17 827-838
    Google Scholar
  • 38 Merleau-Ponty M. The Phenomenology of Perception,. transl. C. Smith New York; Routledge and Kegan Paul 1962
    Google Scholar
  • 39 Minkowski E. La schizophrènie. Psychopathologie des schizoïdes et des schizophrènes. Paris; Payot 1927
    Google Scholar
  • 40 Myerson A. Anhedonia.  Am J Psychiat. 1922;  2 87-111
    PubMedGoogle Scholar
  • 41 Naber D. Neurobiologische und psychopharmakologische Aspekte der Anhedonie. In Heimann H, editor Anhedonie - Verlust der Lebensfreude: Ein zentrales Phänomen psychischer Störungen. Stuttgart; Gustav Fischer Verlag 1990: pp. 131-145
    Google Scholar
  • 42 Pecina S, Berridge D C. Opioid site in nucleus accumbens shell mediates eating and hedonic ’liking‘ for food: map ased on microinjection Fos plumes.  Brain Res. 2000;  863 71-86
    CrossrefPubMedGoogle Scholar
  • 43 Rado S. Psychoanalysis of behavior. New York; Grune und Stratton 1956
    Google Scholar
  • 44 Ricoeur P. Oneself as Another. transl. K. Blamey Chicago; University of Chicago Press 1992
    Google Scholar
  • 45 Robbins T W, Everitt B J. Neurobehavioral mechanisms of reward and motivation.  Curr Opin Neurobiol. 1996;  6 228-236
    CrossrefPubMedGoogle Scholar
  • 46 Robinson T E, Berridge K C. The neural basis of drug craving: an incentive-sensitization theory of addiction.  Brain Res Rev. 1993;  18 247-291
    CrossrefPubMedGoogle Scholar
  • 47 Sass L. Madness and Modernism. New York; Basic Books 1992
    Google Scholar
  • 48 Sass L. Schizophrenia, self-experience, and the so-called ”negative symptoms”. In Zahavi D, editor Exploring the Self: Philosophical and Psychopathological Perspectives on Self-Experience. Amsterdam; John Benjamins 2000: pp. 149-182
    Google Scholar
  • 49 Sass L. Self and world in schizophrenia: Three classic approaches in phenomenological psychiatry.  Philosophy, Psychiatry, Psychology. 2001;  8 251-270
    PubMedGoogle Scholar
  • 50 Sass L, Parnas J. Schizophrenia, consciousness, and the self.  Schizophrenia Bull 2003 (in press)
    Google Scholar
  • 51 Schultz W. Activity of dopamine neurons in the behaving primate.  Prog Neurosci. 1992;  4 129-138
    PubMedGoogle Scholar
  • 52 Schultz W, Dayan P, Montague P R. A neural substrate of prediction and reward.  Science. 1997;  275 1593-1599
    Google Scholar
  • 53 Skinner B F. Science and human behavior. New York; Macmillan 1953
    Google Scholar
  • 54 Stein L, Wise C D. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine.  Science. 1971;  171 1032-1036
    PubMedGoogle Scholar
  • 55 Tomkins D M, Tampakeras M. Effects of discrete central injections of 5-HT1B agonists on ethanol self-administration.  Alc Clin Exp Res. 1999;  23 20A
    PubMedGoogle Scholar
  • 56 Watson J B. Psychology as the behaviorist views it.  Psychol Rev. 1913;  20 158-177
    PubMedGoogle Scholar
  • 57 Weinberger D R. Implications of normal brain development for the pathogenesis of schizophrenia.  Arch Gen Psychiat. 1987;  44 660-669
    PubMedGoogle Scholar
  • 58 Wise R A. Neuroleptics and operant behavior: the anhedonia hypothesis.  Behav Brain Sci. 1982;  5 39-87
    PubMedGoogle Scholar
  • 59 Wise R A. The neurobiology of craving: Implications for the understanding of addiction.  J Abnorm Psychol. 1988;  97 118-132
    CrossrefPubMedGoogle Scholar

Georg Juckel, MD

Department of Psychiatry and Psychotherapy

Charité - University Medicine Berlin

Campus Charité-Mitte (CCM)

Schumannstr. 20/21

10117 Berlin

Germany

Phone: +49 30 450 517 042

Fax: +49 30 450 517 962

Email: georg.juckel@charite.de

      >